AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
The current price of AbbVie Inc in the market is Rp 3.572.844,17, with a 24-hour trading volume of Rp 13,8T. The asset's market cap is Rp 6,31P, after moving -0.01% in the last day.
Tokenized AbbVie Inc is trading at Rp 3.595.385,87, with a tokenized market cap of Rp 245,68B and a 24-hour trading volume of Rp 16,73B. The tokenized asset has moved 0.13% in the past 24 hours.